Adult MDW Dual Cut-Off Accuracy Study

Beckman Coulter, Inc.524 enrolled

Overview

This study will establish the clinical performance of the Monocyte Distribution Width (MDW) parameter on the DxH 900/ DxH 690T hematology analyzers to aid in the detection and risk assessment of patients in the Emergency Department (ED) for progression to sepsis.

The objective of this study is to validate the MDW dual cut-off values established during characterization and demonstrate the performance of MDW to detect sepsis in a multi-center study of adults presenting to the ED who have CBC w/diff ordered within 12 hours of presentation. This study is designed to enroll all-comers from selected sites that currently have a DxH 900 in use as part of routine testing in the ED. All subjects who meet the Inclusion Criteria will be included in the study, without enrichment. Data from all subjects meeting the Inclusion Criteria will be provided to a panel of independent adjudicators. Adjudicators will be blinded to the MDW result and any sepsis diagnostic determinations which may or may not be in the original medical record.

Study Type

OBSERVATIONAL

Enrollment

524

Conditions

Sepsis

Interventions

Complete Blood Count with differentialDIAGNOSTIC_TEST

First CBC w/diff test ordered within 12 hours of presentation to ED as part of standard medical care. The MDW result will be used as diagnostic marker to predict the risk of developing sepsis.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 89 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adults (18 to 89 years) of all races and ethnicities presenting to the ED * Whole Blood venous samples collected in K2EDTA while the patient was in the ED * First CBC w/diff test ordered within 12 hours of presentation to ED as part of their standard medical care * CBC w/diff tested within 2 hours of specimen collection * Subjects with at least ≥12 hours of follow-up in the ED (or inpatient, if admitted) from presentation Exclusion Criteria: * CBC w/diff test ordered after 12 hours of presentation to ED * Subjects previously enrolled in this study (i.e. subjects may not be enrolled more than once in this study) * Subjects discharged from ED \<12 hours from ED presentation * ED Transfer Patients Data Exclusions Post Enrollment: * Samples that have a system generated flag from the Standard of Care (SOC) CBC w/diff testing will be excluded. * Samples with instrument flags, including vote outs and review flags for MDW will also be excluded (i.e. invalid MDW results). * Subjects' data collected with Instrument Quality Control failure(s).

Locations (5)

Indiana University

Indianapolis, Indiana, United States

Kansas University Medical Center

Kansas City, Kansas, United States

Henry Ford Health System

Detroit, Michigan, United States

Truman Medical Center

Kansas City, Missouri, United States

Outcomes

Primary Outcomes

Clinical performance of MDW

Clinical performance of MDW (expressed in terms of its interpretation bands and likelihood ratios) in diagnosing sepsis determined by clinical adjudication.

Time frame: through study completion, an average of 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.